Regeneron Secures FDA Approval for Rare Genetic Disorder Drug

Summary

Regeneron Pharmaceuticals has secured FDA approval for a drug targeting a rare genetic disorder. The approval represents a regulatory milestone for the company's rare disease pipeline.